Comparable assessment of adolescent repeated physical or psychological stress effects on adult cardiac performance in female rats.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
29 09 2023
Historique:
received: 22 04 2023
accepted: 27 09 2023
medline: 5 10 2023
pubmed: 30 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Extensive evidence highlights a robust connection between various forms of chronic stress and cardiovascular disease (CVD). In today's fast-paced world, with chronic stressors abound, CVD has emerged as a leading global cause of mortality. The intricate interplay of physical and psychological stressors triggers distinct neural networks within the brain, culminating in diverse health challenges. This study aims to discern the unique impacts of chronic physical and psychological stress on the cardiovascular system, unveiling their varying potencies in precipitating CVD. Twenty-one adolescent female rats were methodically assigned to three groups: (1) control (n = 7), (2) physical stress (n = 7), and (3) psychological stress (n = 7). Employing a two-compartment enclosure, stressors were administered to the experimental rats over five consecutive days, each session lasting 10 min. After a 1.5-month recovery period post-stress exposure, a trio of complementary techniques characterized by high specificity or high sensitivity were employed to meticulously evaluate CVD. Echocardiography and single-photon emission computed tomography (SPECT) were harnessed to scrutinize left ventricular architecture and myocardial viability, respectively. Subsequently, the rats were ethically sacrificed to facilitate heart removal, followed by immunohistochemistry staining targeting glial fibrillary acidic protein (GFAP). Rats subjected to psychological stress showed a wider range of significant cardiac issues compared to control rats. This included left ventricular hypertrophy [IVSd: 0.1968 ± 0.0163 vs. 0.1520 ± 0.0076, P < 0.05; LVPWd: 0.2877 ± 0.0333 vs. 0.1689 ± 0.0057, P < 0.01; LVPWs: 0.3180 ± 0.0382 vs. 0.2226 ± 0.0121, P < 0.05; LV-mass: 1.283 ± 0.0836 vs. 1.000 ± 0.0241, P < 0.01], myocardial ischemia [21.30% vs. 32.97%, P < 0.001], and neuroinflammation. This outcome underscores the imperative of prioritizing psychological well-being during adolescence, presenting a compelling avenue to curtail the prevalence of CVD in adulthood. Furthermore, extending such considerations to individuals grappling with CVD might prospectively enhance their overall quality of life.

Identifiants

pubmed: 37775558
doi: 10.1038/s41598-023-43721-7
pii: 10.1038/s41598-023-43721-7
pmc: PMC10541905
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16401

Informations de copyright

© 2023. Springer Nature Limited.

Références

Neurosci Biobehav Rev. 2017 Mar;74(Pt B):269-276
pubmed: 27751732
Circulation. 1983 Sep;68(3):470-6
pubmed: 6223721
Cardiovasc Res. 1999 Jan;41(1):41-54
pubmed: 10325952
Physiol Behav. 2003 Mar;78(3):495-504
pubmed: 12676287
Front Cell Neurosci. 2015 Aug 03;9:278
pubmed: 26283915
J Cardiovasc Dev Dis. 2020 Nov 24;7(4):
pubmed: 33255284
Front Behav Neurosci. 2013 Apr 04;7:26
pubmed: 23576965
Ann Anat. 2005 Jul;187(3):225-43
pubmed: 16130822
Ann Intern Med. 2015 Mar 17;162(6):438-47
pubmed: 25775317
Annu Rev Psychol. 2019 Jan 4;70:627-650
pubmed: 30260746
Neuroscience. 2013 Sep 26;249:63-73
pubmed: 23402852
Curr Dir Psychol Sci. 2015 Aug 1;24(4):313-321
pubmed: 26279608
Am J Surg. 1977 Jul;134(1):95-101
pubmed: 879415
Int J Prev Med. 2013 Jun;4(6):624-30
pubmed: 23930179
Nucl Med Commun. 2003 Jul;24(7):779-83
pubmed: 12813196
Brain Behav. 2021 May;11(5):e02139
pubmed: 33811472
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
pubmed: 10817843
Brain Res. 1998 Jul 13;799(1):6-15
pubmed: 9666058
Neurosci Biobehav Rev. 2008 Aug;32(6):1136-51
pubmed: 18468686
J Comp Neurol. 2002 Nov 11;453(2):116-30
pubmed: 12373778
BMJ Open. 2018 Mar 5;8(3):e019434
pubmed: 29567845
Physiol Behav. 2001 Nov-Dec;74(4-5):435-40
pubmed: 11790402
J Nucl Cardiol. 2001 Nov-Dec;8(6):677-86
pubmed: 11725264
ASN Neuro. 2012 Oct 30;4(6):393-408
pubmed: 23025787
Am J Med. 2022 Jun;135(6):688-696
pubmed: 35278355
JAMA. 2007 Oct 10;298(14):1685-7
pubmed: 17925521
iScience. 2020 Jun 26;23(6):101140
pubmed: 32460006
Brain Res. 1993 Apr 16;608(2):216-22
pubmed: 8495356
J Am Coll Cardiol. 2008 Apr 1;51(13):1237-46
pubmed: 18371552
Neuroimmunomodulation. 2009;16(5):300-17
pubmed: 19571591
Metab Brain Dis. 2021 Aug;36(6):1253-1258
pubmed: 33721183
Arch Gen Psychiatry. 2007 Dec;64(12):1393-401
pubmed: 18056547
Biol Reprod. 1994 Mar;50(3):603-6
pubmed: 8167231
Psychoneuroendocrinology. 2020 Apr;114:104599
pubmed: 32045797
Int J Hypertens. 2011;2011:495349
pubmed: 21755036
Neuroscientist. 2005 Oct;11(5):400-7
pubmed: 16151042
Brain Behav Immun. 2013 May;30:88-94
pubmed: 23348027
Health Psychol Open. 2020 Jul 8;7(2):2055102920933072
pubmed: 32704379
Front Neuroendocrinol. 2018 Apr;49:146-169
pubmed: 29551356
Health Behav Policy Rev. 2015 Jan;2(1):62-73
pubmed: 26213688
Annu Rev Public Health. 2013;34:337-54
pubmed: 23297662
Curr Opin Cardiol. 2019 Sep;34(5):531-535
pubmed: 31219875
J Mol Neurosci. 2016 May;59(1):24-35
pubmed: 26790434
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Neurotoxicol Teratol. 2020 Jul - Aug;80:106893
pubmed: 32437941
Eur J Neurosci. 2001 Oct;14(7):1143-52
pubmed: 11683906
J Psychosom Res. 2002 Jan;52(1):1-23
pubmed: 11801260
Stress. 2019 Jan;22(1):123-132
pubmed: 30345860
J Mol Neurosci. 2021 Apr;71(4):804-809
pubmed: 32915417
Iran J Basic Med Sci. 2019 Oct;22(10):1179-1185
pubmed: 31998460
Eur Heart J. 2014 Mar;35(9):578-89
pubmed: 24026779
Neuropathology. 2019 Feb;39(1):14-21
pubmed: 30536911

Auteurs

Monireh-Sadat Mousavi (MS)

Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.

Sogol Meknatkhah (S)

Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.

Alireza Imani (A)

Department of Physiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Parham Geramifar (P)

Research Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Gholamhossein Riazi (G)

Laboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran. ghriazi@ut.ac.ir.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH